论文信息 - Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19. - 字舞流文

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.

J. Teijaro | Wanhong Xu | Lisa Kerwin | Henry Ji | R. Allen | K. Stegman | Yimei Bao | Namir Shaabani | Long Mao | Xiaoying Zhang | Can Jin | Christopher Argent | Yulia Kushnareva | Colin Powers | Jia Liu | Hui Xie | Changxu Xu | Lijun Xu | Yuren Zhang | Haigang Yang | Shengdian Qian | Yong Hu | Jianping Shao | Can Zhang | Tingting Li | Yi Li | Na Liu | Zhenhao Lin | Shanbo Wang | Chao Wang | Wei Shen | Yuanlong Lin | Dan Shu | Zhenhong Zhu | Olivia Kotoi | Qing Han | Ludmila Chumakova | Mike Royal | Mark Brunswick | Hongzhou Lu | Xiao Xu